Host ESCRT Proteins Are Required for Bromovirus RNA Replication Compartment Assembly and Function
Positive-strand RNA {(+)RNA} viruses cause numerous human, animal, and plant diseases. (+)RNA viruses reorganize host intracellular membranes to assemble their RNA replication compartments, which are mini-organelles featuring the close association of both viral and host components. To further understand the role of host components in forming such RNA replication compartments, we used brome mosaic virus (BMV), a well characterized model virus, to study some common features of (+)RNA virus RNA replication. We show that knocking out several components of the cellular Endosomal Complex Required for Transport (ESCRT) machinery resulted in parallel defects in BMV RNA replication and replication compartment formation, whereas other ESCRT components affected RNA replication independently of replication compartment formation. Deleting a subset of ESCRT proteins altered the frequency of replication compartment formation but had no effect on the size of these compartments, whereas a second subset affected RNA replication independently of replication compartment formation. Moreover, BMV’s interaction with the ESCRT machinery appears to be distinct from that reported for other viruses and from the ESCRT requirements for forming vesicles in cellular multivesicular bodies. These findings further illuminate the remarkable abilities of positive-strand RNA viruses to integrate viral and host protein functions to remodel membranes, and suggest potentially potent new ways to control such viruses.
Published in the journal:
Host ESCRT Proteins Are Required for Bromovirus RNA Replication Compartment Assembly and Function. PLoS Pathog 11(3): e32767. doi:10.1371/journal.ppat.1004742
Category:
Research Article
doi:
https://doi.org/10.1371/journal.ppat.1004742
Summary
Positive-strand RNA {(+)RNA} viruses cause numerous human, animal, and plant diseases. (+)RNA viruses reorganize host intracellular membranes to assemble their RNA replication compartments, which are mini-organelles featuring the close association of both viral and host components. To further understand the role of host components in forming such RNA replication compartments, we used brome mosaic virus (BMV), a well characterized model virus, to study some common features of (+)RNA virus RNA replication. We show that knocking out several components of the cellular Endosomal Complex Required for Transport (ESCRT) machinery resulted in parallel defects in BMV RNA replication and replication compartment formation, whereas other ESCRT components affected RNA replication independently of replication compartment formation. Deleting a subset of ESCRT proteins altered the frequency of replication compartment formation but had no effect on the size of these compartments, whereas a second subset affected RNA replication independently of replication compartment formation. Moreover, BMV’s interaction with the ESCRT machinery appears to be distinct from that reported for other viruses and from the ESCRT requirements for forming vesicles in cellular multivesicular bodies. These findings further illuminate the remarkable abilities of positive-strand RNA viruses to integrate viral and host protein functions to remodel membranes, and suggest potentially potent new ways to control such viruses.
Introduction
A universal feature of positive-strand RNA ((+)RNA) viruses is that they multiply their RNA on intracellular membranes, usually in association with vesiculation or other membrane rearrangements [1–3]. Cellular membranes play crucial roles in RNA replication by providing necessary host factors [4–11], serving as a scaffold to localize viral components necessary for viral replication [12], and protecting viral RNA from cellular defense mechanisms [13].
One (+)RNA virus that has been studied as a model for RNA replication is brome mosaic virus (BMV), a member of the alphavirus-like superfamily of human, animal, and plant viruses. BMV is the type member of the bromoviruses, a group of icosahedral, tripartite, (+)RNA viruses that infect plants [14]. BMV can also replicate in the yeast Saccharomyces cerevisiae [15]. The techniques of yeast genetics and molecular biology have greatly facilitated investigation of BMV replication and host-virus interactions [5, 16, 17]. In both yeast and plant cells, BMV RNA replication depends on the viral 1a and 2apol proteins and specific cis-acting RNA signals [18], generates a considerable excess of positive- to negative-strand RNA [15], and efficiently directs subgenomic mRNA synthesis [15]. Additionally, in yeast as in plants, the 1a and 2apol proteins properly localize to the ER [19, 20] and viral RNA is selectively encapsidated into progeny virions [21]. In yeast, replication factor 1a localizes to the outer perinuclear ER membranes and induces 50–75 nm vesicular invaginations or spherules that, in the presence of 2apol and a replicable RNA template, serve as compartments or mini-organelles for RNA replication [22]. Highly similar spherular invaginations of the perinuclear ER membrane are prominent features of natural plant infections by BMV and its close relatives CCMV and BBMV [23, 24], and equivalent invaginations of other membranes are associated with genome replication in plant cells by other Bromoviridae [25], Tymoviridae [26, 27], Tombusviridae [28] and other plant viruses, and in animal cells by human- and animal-infecting alphaviruses [29–31].
The endosomal sorting complex required for transport (ESCRT) machinery is conserved from Archaea to animals and is responsible for the formation of intralumenal vesicles (ILVs) in the biogenesis of multivesicular bodies (MVBs) [32–38]. MVBs are specialized organelles of the endosomal system that are required for lysosomal or vacuolar degradation of membrane proteins [32]. Five ESCRT complexes are recruited sequentially and perform distinct functions in MVB formation. ESCRT-0 clusters ubiquitinated cargo and recruits ESCRT-I, ESCRT-I and ESCRT-II help remodel the membranes and recruit ESCRT-III, which in turn helps mediate membrane fission (Table 1) [35–40]. Finally, through interactions with ESCRT-III components, the AAA ATPase Vps4p and accessory proteins Vta1p, Vps60p, and Did2p help disassemble the ESCRT complexes from the membranes [33, 34, 41]. Parts of the ESCRT machinery also function during cell abscission at the final stage of cytokinesis [35, 42] and during budding of enveloped viruses from the plasma membrane [43–46]. In each case, the ESCRT machinery functions from the cytoplasmic face of the bilayer and invaginates the membrane away from the cytoplasm, thus inducing “negative” membrane curvature.
The spherular replication vesicles induced by BMV and many other (+)RNA viruses share topological similarities with ESCRT-dependent viral budding and MVB vesicles, in that the membrane is invaginated away from the cytoplasm, with a major difference being that such spherules do not pinch off and release from the membrane [22]. The assembly and function of BMV replication complexes further share similarities to the replicative cores of retroviruses and double-stranded RNA viruses [22, 47]. Previous results showed that key components of the ESCRT / MVB pathway, DOA4 and BRO1, were crucial for proper BMV RNA replication [11]. However, the involvement of DOA4 and BRO1 in BMV RNA replication was not dependent on the ESCRT pathway's membrane-shaping functions, but rather on their regulating expression of OLE1, which encodes Δ9 fatty acid desaturase, and other lipid synthesis genes required for BMV RNA replication [11].
ESCRT components are recruited by tomato bushy stunt virus, another (+)RNA virus, to peroxisome membranes, where they promote RNA replication and the assembly of the replicase complex [7, 48]. We had previously shown that the reticulons, a family of morphogenic proteins that partition into and stabilize highly curved ER tubules, regulate spherule size and play crucial roles in forming and/or maintaining the proper structure and function of the BMV RNA replication compartments [4]. To determine if other host factors are required for this process, we systematically examined if components of the various ESCRT complexes are required for proper BMV RNA replication and replication complex formation. We show that knockout of several ESCRT components resulted in parallel defects in RNA replication and spherule formation, whereas other ESCRT components affected RNA replication independently of spherule formation. Unlike the reticulons, which regulate spherule size, deleting any of the four subunits of the ESCRT-III complex only altered spherule frequency and resulted in at least a 5-fold inhibition of BMV RNA replication. In particular, deleting SNF7 inhibited BMV RNA replication by > 25-fold and blocked detectable spherule formation. Moreover, BMV’s interaction with the ESCRT machinery is distinct from that of TBSV and HIV-1, in that BMV 1a interacts strongly with major ESCRT-III effector Snf7p without the necessity for a bridging ESCRT-I protein.
Results
BMV RNA replication is inhibited in specific ESCRT deletion strains
Previously, Kushner et al. screened a yeast single-gene deletion library and identified ~100 genes whose deletion inhibited or enhanced BMV RNA replication by >3-fold [16]. Since many of the ESCRT deletion strains either did not transform or did not grow well in the BY4743 yeast background used for the screen, we deleted individual ESCRT components in the S. cerevisiae YPH500 background. YPH500 has been used in many past studies of the assembly, structure and function of BMV RNA replication compartments [4, 22, 49–52]. Among the strains generated were deletions of components of ESCRT-0 (hse1 Δ), ESCRT-I (vps23 Δ), ESCRT-II (vps36 Δ), ESCRT-III (vps20 Δ, snf7 Δ, vps24 Δ, vps2 Δ) as well as accessory proteins (vps4Δ, did2 Δ, vta1 Δ, vps60) (Table 1). In yeast expressing BMV 1a and 2apol proteins, plasmid-launched positive-strand RNA3 transcripts serve as templates for synthesis of negative-strand RNA3, which in turn is copied to amplify high levels of positive-strand RNA3 and to produce an additional mRNA species, subgenomic RNA4 (Fig. 1A) [15]. To determine the effects of these ESCRT gene knockouts on BMV RNA replication, we measured the accumulation of negative-strand RNA3 and positive-strand subgenomic RNA4, which are produced solely by RNA-dependent RNA synthesis, with no background from plasmid DNA-directed transcription.
Deleting components of ESCRT-0 (hse1 Δ), ESCRT-II (vps36 Δ), or the Vps4 accessory proteins Vta1 and Vps60 did not significantly affect either negative-strand RNA3 or positive-strand RNA4 synthesis (Figs. 1B and S1). Since they had at most minor effects on BMV RNA replication, the vta1 Δ and vps60 Δ strains were used as controls in experiments described in the sections below. A more pronounced effect was observed in the ESCRT-I deletion strain vps23 Δ, resulting in six- and four-fold reductions in positive-strand RNA4 and negative-strand RNA3 levels, respectively (Fig. 1B and Table 2). In turn, deleting Vps4, the AAA ATPase that catalyzes the disassembly of the ESCRT machinery and the recycling of its subunits from membranes [53], reduced positive-strand RNA4 and negative-strand RNA3 production by three- and two-fold, respectively (Fig. 1B). Interestingly, deleting any of the four subunits of the ESCRT-III complex resulted in a 3-fold or greater inhibition of BMV RNA replication. In particular, deleting Vps20 and Snf7 inhibited positive-strand RNA4 replication by 10- and 25-fold, respectively (Fig. 1B). Thus, while multiple ESCRT components are required for efficient BMV RNA replication, the key ESCRT III effector Snf7 in particular appears to be essential for this process.
To rule out that the reduced BMV RNA replication in the ESCRT mutant strains might merely be due to destabilizing effects on the viral RNA replication proteins, we measured 1a and 2apol levels in wt and ESCRT deletion yeast. Western blotting of yeast cells expressing 1a plus 2apol showed that 1a and 2apol levels were not significantly changed in the relevant strains (Fig. 1C and Table 2), indicating that the dramatic effects of multiple ESCRT factor deletions on BMV RNA replication were not due to altered levels of BMV replicase proteins.
1a retains ER membrane localization in the absence of ESCRTs
To test whether the ESCRT proteins influenced 1a’s ability to associate with membranes, we performed a membrane affinity assay. Lysates of yeast cells expressing 1a in the various ESCRT deletion strains were loaded under flotation gradients, which after centrifugation were fractionated and analyzed by SDS PAGE and western blotting using an anti-1a antibody. As a measure of membrane association, flotation efficiency was determined as the percentage of total 1a protein in the gradient that was present in the top two fractions, where membranes and membrane-associated proteins fractionate. In these assays, 1a floated to the top of the gradient with the membrane fraction for all tested deletions, showing that these ESCRT factors are not required for 1a-membrane association (Fig. 2A).
In plant cells and yeast, 1a localizes predominantly at the perinuclear ER [19, 20]. To more precisely determine if 1a still localized to the perinuclear ER in the absence of the relevant ESCRT proteins, we used immunofluorescence confocal miscroscopy. In wt yeast expressing 1a and 2apol, 1a was mainly associated with the perinuclear and to a lesser degree the peripheral ER membrane, and this typical localization of the 1a protein was not altered in any of the ESCRT deletion strains (Fig. 2B and Table 2).
Snf7p interacts with 1a and relocalizes with other ESCRT proteins to BMV RNA replication sites
To determine if the ESCRT proteins might be involved in forming and/or maintaining the BMV-induced membrane rearrangements, we used confocal microscopy to examine the localization of C-terminally HA-tagged versions of Vps23p, Vps20p, Snf7p, Vps4p and Vta1p expressed from their endogenous promoters from centromeric, low-copy number plasmids. Since Vps4 catalyzes ESCRT complex disassembly and recycling from membranes, we performed these confocal microscopy experiments in vps4Δ yeast to help stabilize any potentially transient interactions. In the absence of BMV 1a, consistent with previous reports [54, 55], ESCRT proteins were found in cytoplasmic punctate structures and were absent from the nuclear envelope (Fig. 3A). In contrast, in yeast expressing BMV 1a (Fig. 3B), the vast majority of Vps23p, Snf7p, Vps4p, and Vta1p colocalized with 1a in the perinuclear ER, the site of viral RNA replication in both plant and yeast cells [19, 20]. Interestingly, only a small percentage of Vps20p colocalized with 1a in the perinuclear ER, while the rest was found in punctate cytoplasmic structures (Fig. 3B).
Since expressing BMV 1a without other viral factors strikingly relocalized multiple ESCRT components (Fig. 3B), we tested whether 1a interacted with these ESCRT proteins. Accordingly, we performed coimmunoprecipitation (co-IP) assays in vps4Δ yeast transformed with an empty plasmid or plasmids expressing HA-tagged Vps23p, Vps20p, Snf7p, Vps4p, and Vta1p in the absence or presence of 1a. The yeast cells were lysed in buffer containing ionic (0.1% SDS) and nonionic (1% NP-40) detergents to disrupt membranes, and anti-1a or anti-HA antibodies and protein A sepharose beads were used to precipitate protein complexes. Total cell lysates and the immunoprecipitates eluted from protein A sepharose beads were subjected to SDS-PAGE and immunoblotted using anti-1a or anti-HA antibodies. As expected, on Western blots of lysates that were immunoprecipitated with anti-1a antibodies, a 1a signal was detected for all samples expressing 1a (Fig. 4A, top panel). After immunoprecipitating with anti-HA antibodies, anti-1a antibodies detected 1a only in cells co-expressing Snf7p-HA and 1a (Fig. 4A). Similarly, after immunoprecipitating with anti-1a antibodies, Snf7p-HA was the only ESCRT protein strongly detected by anti-HA antibodies (Fig. 4A). Immunoprecipitating with anti-HA antibody and immunoblotting for HA confirmed that all of the HA-tagged proteins were expressed, although Vps23-HA and Vps20-HA pulled down at lower levels in the presence of 1a (Fig. 4A, bottom panel). The results show that although several ESCRT proteins relocalize to the perinuclear ER in the presence of 1a, only the 1a interaction with Snf7 was preserved under the stringent immunoprecipitation conditions used.
Since 1a immunoprecipitates with Snf7p and we had previously shown that 1a can also interact with and relocalize the reticulons to the perinuclear ER [4], we tested if Rtn1p and Snf7p might interact. Yeast expressing GFP-tagged Rtn1 were transformed with plasmids encoding Snf7-HA and either BMV 1a or no added open reading frame. Although there was some variation in the amount of Rtn1-GFP that pulled down in the IPs, Rtn1p immunoprecipitated with 1a but no signal for Snf7p-HA was detected even in cells co-expressing BMV 1a (Fig. 4B). Since Rtn1p and Snf7p do not co-immunoprecipitate with one another, but each co-immunoprecipites with 1a, these results suggest that Snf7p and the reticulons are independently recruited by 1a to the sites of BMV RNA replication.
Although only Snf7 immunoprecipitated with BMV 1a, several other ESCRT components relocalized to the perinuclear ER in the presence of 1a (Fig. 3B). This observation suggested a possible role for Snf7p in mediating the recruitment of other ESCRT components to the perinuclear ER by 1a. To address this, we repeated the co-localization studies in snf7Δ yeast. As seen in Fig. 3C, Vps23p-HA, Vps20p-HA, and Vta1p-HA failed to co-localize with 1a in the perinuclear ER in the absence of Snf7p, showing that recruitment of other ESCRT components to the site of viral replication is dependent on the presence of Snf7p.
In MVB formation and virus budding, Snf7p is recruited to viral or cellular proteins through interactions with adaptor proteins such as Vps23p and Bro1p (yeast homologs of human TSG101 and ALIX, respectively) [36, 43]. Previous results show that Bro1p is required for BMV RNA replication but this involvement is not dependent on the ESCRT pathway’s membrane-shaping functions but rather on regulating expression of lipid synthesis genes required for BMV RNA replication [11]. To test for a possible role of Bro1p in bridging the Snf7p-1a interaction, two mutations were made in Snf7p (Snf7L231A/L234A) that are known to disrupt its interaction with Bro1p [56]. Additionally, since the interactions between 1a and ESCRT components are transient, the experiments were performed in the presence of Vps4E233Q, a Vps4p mutant that is incapable of mediating ESCRT-III disassembly [57]. In snf7 Δ yeast expressing BMV 1a, Snf7L231A/L234A-HA and Vps4E233Q-FLAG, Snf7L231A/L234A-HA co-localized with 1a in the perinuclear ER, showing that Bro1p is not required for Snf7p to interact with 1a (Fig. 3D). This result is consistent with our previous conclusion that Bro1p’s contribution to BMV RNA replication is independent of the ESCRT pathway’s membrane-shaping functions [11].
Deleting Snf7 abolishes spherule formation
As noted earlier, in wt yeast, expressing 1a alone induces the invagination of the outer, perinuclear ER membrane to form spherular compartments associated with BMV RNA protection and replication [22]. Intriguingly, the frequency and average diameter of these RNA replication vesicles can be changed dramatically by mutating one face of a membrane-interacting 1a amphipathic helix [50], or by knocking out the membrane-shaping host reticulon proteins [4], or a host factor promoting long chain fatty acid accumulation [52].
To determine whether the formation or structure of such spherules was affected by deleting the tested ESCRT proteins, we examined wt and single-knockout yeast by electron microscopy (EM) and measured the abundance and diameter of spherules in the subset of cells that were sectioned through the nucleus among a total of 250 cells for each strain. In wt yeast, the average diameter of spherules was 67 ± 9 nm (Fig. 5B and Table 2), similar to previous results for BMV and other Bromoviridae in yeast [22] and plants [23–25].
Notably, and unlike the results of depleting membrane-shaping reticulons [4], none of the tested ESCRT deletions significantly altered the distribution of spherule diameters (Fig. 5C–F and Table 2). However, deleting certain ESCRT factors reduced the number of spherules formed, which mirrors their inhibitory effects on RNA replication (Fig. 1). Most significantly, deleting SNF7 abolished detectable spherule formation (Fig. 5D and Table 2). Similarly, deleting the Snf7p oligomer capping protein Vps24p or the Snf7p recycling ATPase Vps4p, which reduced RNA4 production to 10–30% of wt, reduced spherule frequency to ~40% of that in wt cells (Fig. 5E–F). The remaining ESCRT deletions (vps2 Δ, 20 Δ, 23 Δ and did2 Δ), which inhibited RNA4 production to 10–33% of wt, produced spherules at 77–90% of normal frequency (Table 2). Thus, these ESCRT genes either alter the replication compartment in ways not visible at the resolution of standard electron microscopy, or are required for other step(s) of RNA replication distinct from forming the replication vesicle. Finally, vta1 Δ, and vps60 Δ yeast, which supported 90% of wt RNA4 production, also supported wt levels of spherule production (Table 2). Thus, while at least some ESCRT-III components and Vps4p are necessary to efficiently form spherules, they are not involved in regulating spherule size. Moreover, Snf7p was the only tested ESCRT component required for this process since detectable spherule formation was abolished in snf7 Δ yeast.
BMV RNA replication and spherule formation are restored by exogenous expression of ESCRT proteins
To further confirm that ESCRT components were necessary for proper BMV RNA replication, we exogenously expressed in each relevant ESCRT deletion strain a C-terminally HA-tagged version of its corresponding deleted protein from its own promoter in a low copy number plasmid, as in Fig. 3. As seen in Fig. 6A, expressing Vps4p-HA and Vps23p-HA in their respective deletion strains restored BMV RNA replication to levels similar to those obtained in wt yeast. Likewise, BMV RNA replication was substantially restored when HA-tagged Vps20p, Vps24p, and Did2p were expressed in their respective yeast deletion strains (Fig. 6A). Any residual reductions in BMV RNA replication from wt yeast might be due to impaired function of the HA-tagged protein, since in vta1 Δ yeast, expressing Vta1p-HA reduced BMV RNA replication levels by two fold from their initially wt level. Most importantly, in snf7 Δ yeast, expressing Snf7p-HA not only increased BMV RNA replication by ~20-fold (Fig. 6A) but also restored spherule formation in the perinuclear ER (Fig. 6B). Spherules were 62 nm in diameter and were present at ~75% frequency compared to those in wt yeast. These results support the observations above that Snf7p is crucial for both spherule formation and BMV RNA replication.
Arabidopsis SNF7 restores BMV RNA replication and spherule formation in snf7 Δ yeast
To complement and provide a foundation for testing the effects of SNF7 on BMV RNA replication in plants, we first cloned AtSNF7–2, the Arabidopsis thaliana homolog of yeast Snf7p, into a yeast vector and expressed it in snf7 Δ yeast. Wild type or snf7 Δ yeast were transformed with plasmids expressing BMV 1a, 2apol, RNA3 and either AtSNF7–2 or an empty plasmid. As shown earlier, positive-strand RNA4 and negative-strand RNA3 accumulation were severely inhibited in the absence of Snf7 (Fig. 7A). However, expressing AtSNF7–2 in snf7 Δ yeast restored RNA4 positive-strand and negative-strand accumulation to 80% and 69% of that in wt yeast (Fig. 7A).
Since AtSNF7–2 restored BMV RNA replication, we next looked at spherule formation. While spherules were not detected in snf7 Δ yeast among thousands of cells examined by EM (Fig. 5D), in snf7 Δ yeast expressing AtSNF7–2, spherules with an average diameter of 66 nm were found in the perinuclear ER at ~70% of their frequency in wt yeast (Fig. 7B). Thus, A. thaliana SNF7–2 is fully compatible with BMV in restoring both BMV RNA replication and spherule formation in snf7 Δ yeast.
Arabidopsis SNF7 mutants dominantly interfere with BMV RNA replication in plants
To test the importance of SNF7 for BMV RNA replication in plants, we turned to N. benthamiana, a systemic host for BMV infection. Agrobacterium infiltration of N. benthamiana plants was used to express Arabidopsis SNF7–2 derivatives C terminally tagged with GFP or the HZZ domain, which contains 6xHis, HA and the ZZ domain of protein A [58]. We used these tagged versions because GFP-tagged SNF7 has been shown to act as a dominant-negative inhibitor of wt SNF7 [7]. Under these conditions, BMV RNA replication was reduced by 72% in plants expressing AtSNF7-HZZ (Fig. 8A). In parallel, we expressed HZZ-tagged yeast RFU1 (regulator of free ubiquitin 1) as a control since RFU1 does not have a homolog in plants. In contrast to the inhibitory effect of AtSNF7-HZZ and AtSNF7-GFP, expressing RFU1-HZZ increased BMV RNA accumulation by ~50% compared to the empty vector.
To determine whether this inhibition by AtSNF7 mutants was specific for BMV or more generally suppresses RNA replication by other plant (+)RNA viruses, we tested tobacco mosaic virus (TMV), which replicates in the perinuclear ER [59], and tobacco rattle virus (TRV), which replicates in mitochondria [60]. Expressing RFU1-HZZ modestly increased TMV RNA replication (Fig. 8B), but overexpressing AtSN7-HZZ had no effect on either TMV or TRV RNA replication in the infiltrated leaves (Fig. 8B–C). Thus, overall, these results show that expressing AtSNF7-HZZ selectively and specifically interfered with BMV RNA replication in plants.
Discussion
Since the assembly of BMV RNA replication complexes shares multiple similarities with budding retroviral virions [22], we investigated whether BMV spherule formation and RNA replication involved components of the ESCRT pathway. We find that deleting ESCRT pathway components results in two distinct phenotypes: one in which the RNA replication defect mirrors a defect in spherule formation, and another in which RNA replication is affected in a way or ways independent of spherule formation (Figs. 1 and 5, Table 2). This is consistent with prior observations that RNA replication requires proper spherule formation as well as other steps and factors [4, 11, 22, 49, 50]. Our results show that a subset of late ESCRT proteins, including Snf7p, Vps24p and Vps4p, are the main contributors to BMV spherule formation (Fig. 5 and Table 2). Snf7p in particular is essential for this process as it co-precipitates with BMV 1a and is recruited to the perinuclear ER (Figs. 3 and 4), it serves as a bridge to recruit other ESCRT components to the perinuclear ER (Fig. 3), and detectable spherule formation is abolished in its absence (Fig. 5 and Table 2).
Below we discuss the roles of Snf7p, Vps4p and associated factors in BMV spherule formation, how the ESCRT dependence of BMV spherule formation differs from that of MVB formation, retrovirus budding and tombusvirus spherule formation, and how some ESCRT factors contribute to BMV replication independently of spherule formation, and compare ESCRT dependence of BMV spherule formation to its dependence on host reticulons, another class of membrane-shaping proteins [4].
Snf7-dependent, Vps23-independent BMV spherule formation
Our results show that ESCRT requirements for MVB vesicle formation and BMV spherule formation differ in important ways. MVB formation requires sequential recruitment of ESCRT-0 to cluster ubiquitinated cargo, the ESCRT-I and-II supercomplex to generate membrane invaginations into the MVB lumen, and ESCRT-III to direct membrane scission and vesicle release [36, 37]. In contrast, BMV spherule formation required ESCRT-III factors and Vps4p, but not ESCRT-0,-I or-II components (Figs. 5 and S1). This also contrasts with HIV-1 and TBSV, which require ESCRT-I factors for virion budding and spherule formation, respectively [7, 61]. HIV-1 Gag interacts with ESCRT-I factor TSG101 and ALIX (human homologs of yeast Vps23p and Bro1p) to recruit ESCRT-III factor CHMP4 (human homolog of yeast Snf7p) to HIV-1 budding sites in a process that bypasses ESCRT-II [44, 61]. Similarly, TBSV p33 interacts with Vps23p (TSG101) and Bro1p (ALIX), and these interactions appear to be required to recruit other ESCRT components to form the RNA replication compartments [7].
BMV spherule formation did not require ESCRT-0, I or II, but was sensitive to ESCRT-III components and Vps4p (Figs. 5 and S1). Most notable were the lack of BMV spherule formation (Fig. 5) and ~25-fold reduction in RNA replication (Fig. 1B) in snf7 Δ yeast. Both spherule formation and BMV RNA replication in snf7 Δ yeast were restored upon ectopic expression of HA-tagged Snf7p (Fig. 6), confirming the origin of these striking defects. Interestingly, in the absence of Snf7p there was a less pronounced effect on negative-strand than on positive-strand synthesis. Among many possible reasons for this, negative-strand synthesis might begin concomitantly with or soon after 1a initiates membrane invagination, but positive-strand synthesis might not proceed until the vesicle is fully enclosed. Importantly, the critical importance of Snf7p for BMV RNA replication is not restricted to yeast, as overexpressing a dominant-negative mutant of Arabidopsis homolog SNF7–2 in N. benthamiana plants inhibited BMV RNA replication, but had no effect on two other plant positive-strand RNA viruses (Fig. 8). In keeping with these results, wt Arabidopsis SNF7–2 restored BMV spherule formation and RNA replication in snf7 Δ yeast (Fig. 7). Consistent with a direct role in spherule formation, upon BMV 1a expression, Snf7p re-localized to the perinuclear ER and was the only ESCRT component to co-immunoprecipitate with 1a (Figs. 3 and 4).
Unlike HIV-1 or TBSV, loss of TSG101 homolog Vps23p did not affect BMV spherule formation (Fig. 5C and Table 2). Moreover, while HIV-1 and TBSV recruit CHMP4/Snf7p and possibly other ESCRT-III factors through bridging interactions with the ESCRT-I factor TSG101/Vps23p, Vps23p did not pull down any detectable 1a under the same conditions that showed strong Snf7p-1a co-immunoprecipitation (Fig. 4A). Thus, while Vps23p also re-localized to the perinuclear ER in the presence of 1a (Fig. 3A, B), any Vps23p-1a interaction is indirect, transient and/or weak (Fig. 4A). Absence of demonstrable 1a-Vps23p interaction is not surprising since 1a lacks any of the L-domains previously characterized in HIV-1 and other retroviruses. Consistent with the notion that 1a does not interact with Vps23p directly and/or stably, our data further shows that Vps23p recruitment to the perinuclear ER and co-localization with 1a is dependent on Snf7p (Fig. 3C). Thus, BMV must initiate ESCRT-III recruitment and spherule vesicle assembly using different protein-protein interactions from those of MVB vesicles, HIV-1 virion budding and TBSV spherule formation. Such variations in the nature of ESCRT interactions might explain in part why BMV spherules remain connected to their parent membrane, unlike MVB vesicles and HIV-1 virions.
Roles of other late ESCRT factors in BMV spherule formation
Yeast ESCRT-III factors Vps20p, Snf7p, Vps24p, and Vps2p are sequentially recruited to membranes and in vitro function together to deform membranes [40], including forming intralumenal vesicles [37]. Thus, in addition to the block to spherule formation in snf7 Δ yeast, the 2.5-fold reduced frequency of spherules in vps24 Δ and vps4Δ yeast (Fig. 5) argues for the active roles of these proteins in spherule formation, and the lesser reductions in vps20 Δ, vps2 Δ, and did2 Δ yeast suggest accessory roles. In keeping with this, BMV RNA replication was reduced ~ 3- to 5-fold in these strains (Fig. 1B and Table 2). Overall, the variable importance of different ESCRT-III components for BMV spherule formation is similar to HIV-1 virion budding, for which only Snf7p (CHMP4) and Vps2p (CHMP2) are strongly required, while other ESCRT-III proteins have much lesser effects [43].
The likely roles of Vps2p, Vps20p, Vps24p and Vps4p in BMV spherule formation are suggested by their known functions and interactions with Snf7p: Vps20p triggers polymerization of coiled, membrane-deforming Snf7p filaments that are capped by Vps24p and Vps2p, which in turn recruit Vps4p for ESCRT-III disassembly and recycling [62]. Thus, Vps24p capping of Snf7p filaments may enhance their function in spherule formation. Similarly, Vps20p may promote BMV spherule formation by helping to activate Snf7p filament assembly, although reduced but continuing spherule formation in vps20 Δ yeast implies an alternate trigger for Snf7p assembly, possibly through a 1a-Snf7p interaction (Fig. 4A).
Vps4p might contribute to BMV spherule formation in at least two ways. First, Vps4p-mediated disassembly is presumably required to recycle ESCRT-III factors to form new spherules. Residual spherule formation in vps4Δ yeast may occur because these dividing cells actively produce new ESCRT-III factors. Second, multiple results suggest that the Vps4p ATPase plays more active functions than simply recycling ESCRT factors, as in contributing energy for membrane deformation or scission [63, 64]. In turn, decreased spherule formation in the absence of Vps24p, Vps2p and Did2p may be due to their contributions to recruiting Vps4p (Table 1). Interestingly, the roles of Vps4p in TBSV and BMV spherule formation differ in that for TBSV vps4Δ yeast only formed vestigial, crescent-shaped membrane deformations [48], while for BMV vps4Δ yeast supported a reduced frequency of spherules of normal shape and size (Fig. 5F).
ESCRT roles in BMV RNA replication independent of spherule formation
Although Vps23p is dispensable for BMV spherule formation (unlike TBSV), VPS23 deletion reduced BMV RNA replication ~6-fold (Fig. 1B). Similarly, VPS20 and DID2 deletion induced much greater reductions in BMV RNA replication than spherule formation (Figs. 1B, 5 and Table 2). While the specific roles of these ESCRT factors in RNA replication are not yet clear, one potentially unifying explanation might involve their interactions with the Doa4p deubiquitinase. We previously showed that deleting DOA4 or its activator BRO1 suppresses BMV RNA replication not due to their links to ESCRT membrane-shaping functions, but rather to depleting free ubiquitin and thereby inhibiting transcriptional induction of certain lipid synthesis genes required for functional lipid composition of the membranes surrounding spherules [11, 65]. Both Vps23p and Vps20p bind Doa4p [66, 67], and mutating Vps20p’s Doa4 binding site exacerbates the deubiquitination defect in cells lacking Bro1 [67]. Thus Vps20p and perhaps Vps23p may help to activate Doa4p’s deubiquitinase activity to support BMV RNA replication. Similarly, while a detailed mechanism awaits further details, Did2p was originally identified as the site of a mutation that suppressed Doa4p mutational defects [68].
Potential model for BMV spherule formation
Based on insights from electron microscope tomography, a new model for HIV budding was proposed in which HIV-1 Gag accumulates at the membrane, forming a partial shell that leads to plasma membrane invagination. Subsequently, Gag recruits ESCRT-I and—III factors, which constrict the initially wide membrane rim induced by Gag assembly, contributing further membrane bending to complete formation and budding of a full, vesicular membrane envelope lined by a partial Gag shell [69].
Similarly, our recent results show that 1a parallels HIV-1 Gag in achieving high-level multimerization on the ER membrane, and implicate this 1a multimerization as one critical driver of membrane invagination [49], perhaps explaining why ESCRT-I and ESCRT-II are dispensable for BMV spherule formation (Fig. 5). A model combining these results on 1a multimerization [49] and reticulon interaction [4] with the present ESCRT results is shown in Fig. 9. Accordingly, 1a multimerization would initiate perinuclear ER membrane invagination away from the cytoplasm (Fig. 9A), followed by recruitment of Snf7p and other ESCRT-III components to constrict the wide membrane rim induced by 1a, further forming the vesicular spherule body and narrowing the vesicle neck to its final dimensions (Fig. 9B). Snf7p assembles coiled filaments that constrict membranes [70], and most mechanistic models envision that membrane constriction occurs as the filaments slide past each other to tighten and close the coil [71].
While ESCRT-III constriction continues to cleave the vesicle neck to release MVB intralumenal vesicles and HIV-1 virions, BMV avoids this step, leaving the spherule neck stably attached to the ER membrane as neck scission might be blocked by 1a, host factors or both. One possibility shown in Fig. 9C is that neck scission is blocked by host reticulons, another class of host membrane-shaping proteins that are independently recruited by 1a (Fig. 4B), stabilize positive membrane curvature as in spherule necks, and are required for BMV spherule formation and RNA replication [4]. Consistent with this model, protein scaffolds that stabilize high membrane curvature [72], like those formed by the reticulons (Rtn), inhibit membrane fission [73].
We had previously shown that the reticulons coimmunoprecipitate with 1a and are recruited to the interior of the spherules. Moreover, since the reticulons regulate spherule size and play crucial roles in forming and/or maintaining the proper structure and function of the BMV replication compartments, they remain stably associated within the spherules (Fig. 9D and [4]). In contrast, the association of ESCRT components with spherules is transient, since visualizing these associations required deleting VPS4 (Figs. 3 and 4). Thus, in the presence of active Vps4p, ESCRT components are released from spherules and recycled as for MVBs. Interestingly, while modulating reticulon levels alters the diameter of BMV spherules [4], deleting ESCRT genes only modulated the number of spherules formed, with no significant effect on their size (Fig. 5 and Table 2). This responsiveness of spherule size correlates and is likely mechanistically linked to the stable association of the curvature-modulating reticulons with BMV spherules, compared to the transient association of ESCRT components during spherule formation. Further understanding of the detailed nature and ultrastructure of these interactions should provide additional means to control and potentially to use the remarkable abilities of positive-strand RNA viruses to remodel membranes and to selectively capture and replicate RNAs.
Materials and Methods
Yeast and plasmids
Yeast strain YPH500 and culture conditions were as described previously [15]. The following strains were generated for this work: hse1Δ (YPH500 hse1::kanMX4), vps23Δ (YPH500 vps23::kanMX4), vps36Δ (YPH500 vps36::kanMX4), vps20Δ (YPH500 vps20::kanMX4), snf7Δ (YPH500 snf7::kanMX4), vps24Δ (YPH500 vps24::kanMX4), vps2Δ (YPH500 vps2::kanMX4), vps4Δ (YPH500 vps4::kanMX4), vps60Δ (YPH500 vps60::kanMX4), did2Δ (YPH500 did2::kanMX4), vta1Δ (YPH500 vta1::kanMX4). Genomic replacements were made using amplified KanMX4 cassettes flanked by 5’ and 3’ homologous recombination regions. The strain expressing the chromosomal alleles of RTN1 as a GFP fusion was obtained from Invitrogen (Carlsbad, CA). For endogenous expression of ESCRT proteins, the coding region of the full-length protein plus the ~500 base-pair upstream sequences were PCR amplified from wt yeast DNA with appropriate primers and inserted into a CEN plasmid. An HA- or a FLAG-tag was added at the C-terminus of the ESCRT ORFs. Snf7L231A/L234A-HA and Vps4E233Q-FLAG were created by site directed mutagenesis.
To express Arabidopsis thaliana SNF7–2 in the yeast snf7Δ mutant strain, AtSNF7–2 cDNA was amplified by PCR and inserted into ycpLAC33, a CEN plasmid. An HA tag sequence is attached to the 3’ end of AtSNF7–2 coding sequence and expression is under the control of the GAL1 promoter. Plasmids expressing the dominant negative mutant of AtSNF7–2, SNF7-HZZ, was made by adding the sequence of the HZZ multitag from pBG1805 at the 3’ end of AtSNF7–2 using PCR. The multitag from pBG1805 contains 6×His, HA, and the ZZ domain of protein A [58]. AtSNF7-HZZ was cloned into agrobacterium binary vector pCAMBIA1300 under the control of an enhanced CaMV 35S promoter to make pAG2P-S7-HZZ. To make pMDC-RFU1-HZZ to overexpress yeast RFU1 in plants, the RFU1 gene in pBG1805 (a Gateway destination vector) was mobilized to a Gateway entry vector first and then to the Gateway-based binary vector pMDC32 [74], which expresses target genes using the enhanced CaMV 35S promoter. BMV 1a was expressed under control of the GAL1 promoter using pB1YT3L, a pB3YT3 [75] derivative with a LEU marker, 2apol was expressed from pB2CT15 (ADH1 promoter) [15] and BMV RNA3 was expressed under control of a CUP1 promoter from pB3VG128H, or under control of a GAL1 promoter from pB3MS82, both RNA3 derivatives have a four-nucleotide insertion in the coat protein gene that abolishes expression of the coat protein [76]. To make plasmids launching BMV RNAs mediated by agrobacterium infiltration, overlapping PCR was used to add a CaMV 35S promoter sequence to the 5’ end and a ribozyme from hepatitis delta virus to the 3’ end of the cDNAs of BMV. The BMV launching cassettes were then cloned into pCAMBIA1300 via EcoRI and PstI digestions. Plasmids launching tobacco mosaic virus (TMV) and tobacco rattle virus (TRV) by agroinfiltration were pTRBO [77] and pTRV-1 and-2 [78].
BMV replication assays in plants
N. benthamiana plants were grown in a growth chamber under long day conditions (16 h light and 8 h dark) at 26°C. Agrobacterium infiltrations were performed following a protocol described by Bendahmane et al. 2000 [79]. Agrobacteria cultures were grown at 30°C in medium with kanamycin (50 mg/L), 10 mM MES (morpholine ethanesulfonic acid, ph 5.9), and 50 uM acetosynringone. These were subcultured once and harvested when the OD600 reached 0.8–1.0. Agrobacterial cells were brought to OD600 = 1.0 in the infiltration solution (10 mM MgCl2, 10 mM MES, pH 5.9, and 150uM acetosynringone) and incubated at room temperature for at least 3 hours. These cultures were then mixed for co-infiltration suspensions with final concentrations listed as followings: BMV RNA1, 2, or 3 at OD600 = 0.05; pTRBO, pTRV-1 and pTRV-2 at OD600 = 0.25; pMD32-RFU1, or pAG2P-HZZ at OD600 = 0.5. The aforementioned culture combinations were co-infiltrated into 8-week-old plants. After 48 hours, the infiltrated leaves were harvested for RNA extraction. Plants infiltrated with BMV only or co-infiltrated with pMDC32-RFU1-HZZ were used as controls. For the Northern blot in Fig. 8B, the first lane of the SNF7-HZZ samples was excluded from quantitative analysis since the RNAs migrated more slowly through the gel due to some salt contamination.
Membrane flotation assay
Ten OD600 units of yeast cells grown to mid-logarithmic phase were spheroplasted and resuspended in 350 μl buffer TNE (50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 5 mM EDTA, 5 mM benzamidine, 1 mM PMSF, and 10 μg/ml each aprotinin, leupeptin, and pepstatin A). Spheroplasts were lysed via 25 passes through a 22 gauge, 4 cm long needle. Total lysates were centrifuged for 5 minutes at 4°C at 500×g to remove cell debris, and 250 μl of supernatants were mixed with 500 μl of 60% Optiprep (Axis-Shield, Oslo, Norway). Density gradient centrifugation was performed for 2 hours at 55,000 rpm in a Beckman TLS55 rotor using 600 μl of each sample overlaid by 1.4 ml of 30% Optiprep and 100 μl of lysis buffer [80]. After centrifugation, 6 fractions were collected from top to bottom of the gradient. For protein detection, samples were boiled in SDS loading buffer prior to SDS-PAGE and western blotting.
RNA and protein analysis
Total yeast RNA isolation by the hot phenol method, Northern blot analysis, total protein extractions and Western blot analysis, and anti-1a, anti-2apol, anti-Dpm1, anti-FLAG and anti-Pgk1 antibodies were as described [4, 15, 81, 82]. Mouse anti-PDI was acquired from Abcam, rabbit and mouse anti-HA antibodies were purchased from Santa Cruz and Roche, respectively. Mouse anti-GFP was purchased from Covance. Northern blots were imaged on a Typhoon 9200 (Amersham Biosciences, Piscataway, NJ). Band intensities were analyzed by using ImageQuant software (Molecular Dynamics, Piscataway, NJ).
Coimmunoprecipitation
Yeast cells were lysed in RIPA buffer (1% NP-40, 0.1% SDS, 50 mM Tris pH 8.0, 150 mM NaCl, 0.5% Sodium deoxycholate, 5 mM EDTA, 10 mM NaF, 10 mM NaPPi, 2 mM phenylmethylsulfonyl, 5mM benzamidine, and 10 ug/ml each of chymostatin, pepstatin A, leupeptin, bestatin) using glass beads and a bead beater and the supernatant was collected after centrifugation. For immunoprecipitation, yeast lysates were mixed with Protein A Sepharose beads (GE Healthcare. Piscataway, NJ) and anti-1a, anti-HA, or anti-GFP antibodies overnight at 4°C. Beads were pelleted and washed with RIPA buffer before boiling in 1x SDS gel loading buffer and running samples in 4–15% SDS-PAGE gels.
Immunofluorescence and confocal microscopy
Confocal microscopy was as described [80]. Briefly, to detect the subcellular localization of BMV proteins in ESCRT deletion strains, yeast were transformed with plasmids expressing BMV 1a and 2apol proteins. To detect the localization of the ESCRT proteins, HA-tagged ESCRTs were transformed with empty plasmids or plasmids encoding BMV 1a. Cells were fixed with 4% formaldehyde, spheroplasted with lyticase, and permeabilized with 0.1% Triton X-100. Spheroplasts were then stained either by using rabbit anti-1a serum, mouse anti-PDI, mouse anti-HA antibodies or combinations thereof followed by anti-rabbit or anti-mouse secondary antibodies conjugated to Alexa-488, or Alexa-568. For nuclear staining, a 10-minute incubation with 300 nM DAPI (Invitrogen) was added after secondary antibody incubation. Fluorescent images were acquired with a Nikon A1R Bio-Rad inverted confocal microscope system. To avoid spectral bleed-through in the multi-color imaging, images were acquired by sequentially scanning with the individual lasers and detecting fluorescence in each channel to coincide with laser illumination.
Electron microscopy
Samples were prepared for electron microscopy as described [22]. In brief, yeast cells were fixed for 1 hr with 2% glutaraldehyde and 4% paraformaldehyde, washed, and post-fixed for 1 hr with 1% OsO4 and 1% uranyl acetate. Cells then were dehydrated via a series of step-wise increasing ethanol concentrations ranging from 50% to 100%, and infiltrated and embedded with Spurr’s resin. Samples were sectioned and placed on nickel grids, washed, and incubated for 15 min in 2% glutaraldehyde, post-stained with 8% uranyl acetate and Reynold's lead citrate, and viewed with a Philips CM120 microscope. For each deletion strain, the diameter of >50 spherules were measured with the imaging program ITEM Analysis (Soft Imaging Systems, Lakewood, Colo.).
Supporting Information
Zdroje
1. Novoa RR, Calderita G, Arranz R, Fontana J, Granzow H, Risco C. Virus factories: associations of cell organelles for viral replication and morphogenesis. Biol Cell. 2005 Feb;97[2]:147–72. 15656780
2. den Boon JA, Diaz A, Ahlquist P. Cytoplasmic viral replication complexes. Cell Host Microbe. 2010 Jul 22;8[1]:77–85. doi: 10.1016/j.chom.2010.06.010 20638644
3. Mackenzie J. Wrapping things up about virus RNA replication. Traffic. 2005 Nov;6[11]:967–77. 16190978
4. Diaz A, Wang X, Ahlquist P. Membrane-shaping host reticulon proteins play crucial roles in viral RNA replication compartment formation and function. Proc Natl Acad Sci U S A. 2010 Aug 30.
5. Ahlquist P, Noueiry AO, Lee WM, Kushner DB, Dye BT. Host factors in positive-strand RNA virus genome replication. J Virol. 2003 Aug;77[15]:8181–6. 12857886
6. Panavas T, Serviene E, Brasher J, Nagy PD. Yeast genome-wide screen reveals dissimilar sets of host genes affecting replication of RNA viruses. Proc Natl Acad Sci U S A. 2005 May 17;102[20]:7326–31. 15883361
7. Barajas D, Jiang Y, Nagy PD. A unique role for the host ESCRT proteins in replication of Tomato bushy stunt virus. PLoS Pathog. 2009 Dec;5[12]:e1000705. doi: 10.1371/journal.ppat.1000705 20041173
8. Belov GA, Ehrenfeld E. Involvement of cellular membrane traffic proteins in poliovirus replication. Cell Cycle. 2007 Jan 1;6[1]:36–8. Epub 2007/01/25. eng. 17245115
9. Hsu NY, Ilnytska O, Belov G, Santiana M, Chen YH, Takvorian PM, et al. Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell. 2010 May 28;141[5]:799–811. Epub 2010/06/01. eng. doi: 10.1016/j.cell.2010.03.050 20510927
10. Heaton NS, Randall G. Multifaceted roles for lipids in viral infection. Trends Microbiol. 2011 Jul;19[7]:368–75. Epub 2011/05/03. eng. doi: 10.1016/j.tim.2011.03.007 21530270
11. Wang X, Diaz A, Hao L, Gancarz B, den Boon JA, Ahlquist P. Intersection of the multivesicular body pathway and lipid homeostasis in RNA replication by a positive-strand RNA virus. Journal of virology. 2011 Jun;85[11]:5494–503. Epub 2011/03/25. eng. doi: 10.1128/JVI.02031-10 21430061
12. Kopek BG, Perkins G, Miller DJ, Ellisman MH, Ahlquist P. Three-dimensional analysis of a viral RNA replication complex reveals a virus-induced mini-organelle. PLoS Biol. 2007 Sep;5[9]:e220. 17696647
13. Haller O, Kochs G, Weber F. The interferon response circuit: induction and suppression by pathogenic viruses. Virology. 2006 Jan 5;344[1]:119–30. 16364743
14. Ahlquist P. Bromovirus RNA replication and transcription. Curr Opin Genet Dev. 1992 Feb;2[1]:71–6. 1378769
15. Janda M, Ahlquist P. RNA-dependent replication, transcription, and persistence of brome mosaic virus RNA replicons in S. cerevisiae. Cell. 1993 Mar 26;72[6]:961–70. 8458084
16. Kushner DB, Lindenbach BD, Grdzelishvili VZ, Noueiry AO, Paul SM, Ahlquist P. Systematic, genome-wide identification of host genes affecting replication of a positive-strand RNA virus. Proc Natl Acad Sci U S A. 2003 Dec 23;100[26]:15764–9. 14671320
17. Gancarz BL, Hao L, He Q, Newton MA, Ahlquist P. Systematic identification of novel, essential host genes affecting bromovirus RNA replication. PLoS One. 2011;6[8]:e23988. Epub 2011/09/15. eng. doi: 10.1371/journal.pone.0023988 21915247
18. Sullivan ML, Ahlquist P. A brome mosaic virus intergenic RNA3 replication signal functions with viral replication protein 1a to dramatically stabilize RNA in vivo. J Virol. 1999 Apr;73[4]:2622–32. 10074107
19. Restrepo-Hartwig M, Ahlquist P. Brome mosaic virus RNA replication proteins 1a and 2a colocalize and 1a independently localizes on the yeast endoplasmic reticulum. J Virol. 1999 Dec;73[12]:10303–9. 10559348
20. Restrepo-Hartwig MA, Ahlquist P. Brome mosaic virus helicase- and polymerase-like proteins colocalize on the endoplasmic reticulum at sites of viral RNA synthesis. J Virol. 1996 Dec;70[12]:8908–16. 8971020
21. Krol MA, Olson NH, Tate J, Johnson JE, Baker TS, Ahlquist P. RNA-controlled polymorphism in the in vivo assembly of 180-subunit and 120-subunit virions from a single capsid protein. Proc Natl Acad Sci U S A. 1999 Nov 23;96[24]:13650–5. 10570127
22. Schwartz M, Chen J, Janda M, Sullivan M, den Boon J, Ahlquist P. A positive-strand RNA virus replication complex parallels form and function of retrovirus capsids. Mol Cell. 2002 Mar;9[3]:505–14. 11931759
23. Kim KS. An ultrastructural study of inclusions and disease development in plant cells infected by Cowpea Chlorotic Mottle virus. J Gen Virol. 1977;35:535–43.
24. Francki RIB. The Plant viruses. New York: Plenum Press; 1985.
25. Hatta T, and Francki RIB. Cytopathic structures associated with tonoplasts of plant cells infected with cucumber mosaic and tomato aspermy viruses. J Gen Virol. 1981;53:343–6.
26. Hatta T, Bullivant S, Matthews RE. Fine structure of vesicles induced in chloroplasts of Chinese cabbage leaves by infection with turnip yellow mosaic virus. J Gen Virol. 1973 Jul;20[1]:37–50. 4584930
27. Prod'homme D, Le Panse S, Drugeon G, Jupin I. Detection and subcellular localization of the turnip yellow mosaic virus 66K replication protein in infected cells. Virology. 2001 Mar 1;281[1]:88–101. 11222099
28. Burgyan J, Rubino L, Russo M. The 5'-terminal region of a tombusvirus genome determines the origin of multivesicular bodies. J Gen Virol. 1996 Aug;77 (Pt 8):1967–74. 8760449
29. Spuul P, Balistreri G, Hellstrom K, Golubtsov AV, Jokitalo E, Ahola T. Assembly of Alphavirus Replication Complexes from RNA and Protein Components in a Novel Trans-replication System in Mammalian Cells. Journal of virology. 2011 Mar 9. Epub 2011/03/11. Eng.
30. Froshauer S, Kartenbeck J, Helenius A. Alphavirus RNA replicase is located on the cytoplasmic surface of endosomes and lysosomes. J Cell Biol. 1988 Dec;107(6 Pt 1):2075–86. 2904446
31. Raghow RS, Grace TD, Filshie BK, Bartley W, Dalgarno L. Ross River virus replication in cultured mosquito and mammalian cells: virus growth and correlated ultrastructural changes. J Gen Virol. 1973 Oct;21:109–22. 4357368
32. Gruenberg J, Stenmark H. The biogenesis of multivesicular endosomes. Nature reviews Molecular cell biology. 2004 Apr;5[4]:317–23. Epub 2004/04/09. eng. 15071556
33. Henne WM, Buchkovich NJ, Emr SD. The ESCRT pathway. Dev Cell. 2011 Jul 19;21[1]:77–91. Epub 2011/07/19. eng. doi: 10.1016/j.devcel.2011.05.015 21763610
34. Hurley JH. ESCRT complexes and the biogenesis of multivesicular bodies. Curr Opin Cell Biol. 2008 Feb;20[1]:4–11. Epub 2008/01/29. eng. doi: 10.1016/j.ceb.2007.12.002 18222686
35. Hurley JH, Hanson PI. Membrane budding and scission by the ESCRT machinery: it's all in the neck. Nature reviews Molecular cell biology. 2010 Aug;11[8]:556–66. Epub 2010/07/01. eng. doi: 10.1038/nrm2937 20588296
36. Wollert T, Hurley JH. Molecular mechanism of multivesicular body biogenesis by ESCRT complexes. Nature. 2010 Apr 8;464(7290):864–9. Epub 2010/03/23. eng. doi: 10.1038/nature08849 20305637
37. Wollert T, Wunder C, Lippincott-Schwartz J, Hurley JH. Membrane scission by the ESCRT-III complex. Nature. 2009 Mar 12;458(7235):172–7. Epub 2009/02/24. eng. doi: 10.1038/nature07836 19234443
38. Wollert T, Yang D, Ren X, Lee HH, Im YJ, Hurley JH. The ESCRT machinery at a glance. Journal of cell science. 2009 Jul 1;122(Pt 13):2163–6. Epub 2009/06/19. eng. doi: 10.1242/jcs.029884 19535731
39. Hurley JH, Emr SD. The ESCRT complexes: structure and mechanism of a membrane-trafficking network. Annu Rev Biophys Biomol Struct. 2006;35:277–98. Epub 2006/05/13. eng. 16689637
40. Saksena S, Wahlman J, Teis D, Johnson AE, Emr SD. Functional reconstitution of ESCRT-III assembly and disassembly. Cell. 2009 Jan 9;136[1]:97–109. Epub 2009/01/13. eng. doi: 10.1016/j.cell.2008.11.013 19135892
41. Alonso YAM, Teis D. Assembly and disassembly of the ESCRT-III membrane scission complex. FEBS letters. 2011 Sep 9. Epub 2011/10/01. Eng.
42. Saksena S, Emr SD. ESCRTs and human disease. Biochem Soc Trans. 2009 Feb;37(Pt 1):167–72. Epub 2009/01/16. eng. doi: 10.1042/BST0370167 19143624
43. Morita E, Sandrin V, McCullough J, Katsuyama A, Baci Hamilton I, Sundquist WI. ESCRT-III protein requirements for HIV-1 budding. Cell host & microbe. 2011 Mar 17;9[3]:235–42. Epub 2011/03/15. eng.
44. Morita E, Sundquist WI. Retrovirus budding. Annual review of cell and developmental biology. 2004;20:395–425. Epub 2004/10/12. eng. 15473846
45. Bieniasz PD. The cell biology of HIV-1 virion genesis. Cell Host Microbe. 2009 Jun 18;5[6]:550–8. doi: 10.1016/j.chom.2009.05.015 19527882
46. Watanabe T, Sorensen EM, Naito A, Schott M, Kim S, Ahlquist P. Involvement of host cellular multivesicular body functions in hepatitis B virus budding. Proceedings of the National Academy of Sciences of the United States of America. 2007 Jun 12;104[24]:10205–10. Epub 2007/06/07. eng. 17551004
47. Ahlquist P. Parallels among positive-strand RNA viruses, reverse-transcribing viruses and double-stranded RNA viruses. Nat Rev Microbiol. 2006 May;4[5]:371–82. 16582931
48. Barajas D, Martin IF, Pogany J, Risco C, Nagy PD. Noncanonical Role for the Host Vps4 AAA+ ATPase ESCRT Protein in the Formation of Tomato Bushy Stunt Virus Replicase. PLoS Pathog. 2014 Apr;10[4]:e1004087. doi: 10.1371/journal.ppat.1004087 24763736
49. Diaz A, Gallei A, Ahlquist P. Bromovirus RNA Replication Compartment Formation Requires Concerted Action of 1a's Self-Interacting RNA Capping and Helicase Domains. Journal of virology. 2012 Jan;86[2]:821–34. Epub 2011/11/18. eng. doi: 10.1128/JVI.05684-11 22090102
50. Liu L, Westler WM, den Boon JA, Wang X, Diaz A, Steinberg HA, et al. An Amphipathic alpha-Helix Controls Multiple Roles of Brome Mosaic Virus Protein 1a in RNA Replication Complex Assembly and Function. PLoS Pathog. 2009 Mar;5[3]:e1000351. doi: 10.1371/journal.ppat.1000351 19325881
51. Schwartz M, Chen J, Lee WM, Janda M, Ahlquist P. Alternate, virus-induced membrane rearrangements support positive-strand RNA virus genome replication. Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11263–8. 15280537
52. Zhang J, Diaz A, Mao L, Ahlquist P, Wang X. Host acyl coenzyme A binding protein regulates replication complex assembly and activity of a positive-strand RNA virus. Journal of virology. 2012 May;86[9]:5110–21. Epub 2012/02/22. eng. doi: 10.1128/JVI.06701-11 22345450
53. Babst M, Wendland B, Estepa EJ, Emr SD. The Vps4p AAA ATPase regulates membrane association of a Vps protein complex required for normal endosome function. The EMBO journal. 1998 Jun 1;17[11]:2982–93. Epub 1998/06/26. eng. 9606181
54. Babst M, Katzmann DJ, Snyder WB, Wendland B, Emr SD. Endosome-associated complex, ESCRT-II, recruits transport machinery for protein sorting at the multivesicular body. Dev Cell. 2002 Aug;3[2]:283–9. Epub 2002/08/27. eng. 12194858
55. Babst M, Katzmann DJ, Estepa-Sabal EJ, Meerloo T, Emr SD. Escrt-III: an endosome-associated heterooligomeric protein complex required for mvb sorting. Dev Cell. 2002 Aug;3[2]:271–82. Epub 2002/08/27. eng. 12194857
56. Wemmer M, Azmi I, West M, Davies B, Katzmann D, Odorizzi G. Bro1 binding to Snf7 regulates ESCRT-III membrane scission activity in yeast. The Journal of cell biology. 2011 Jan 24;192[2]:295–306. Epub 2011/01/26. eng. doi: 10.1083/jcb.201007018 21263029
57. Davies BA, Azmi IF, Payne J, Shestakova A, Horazdovsky BF, Babst M, et al. Coordination of substrate binding and ATP hydrolysis in Vps4-mediated ESCRT-III disassembly. Mol Biol Cell. 2010 Oct 1;21[19]:3396–408. doi: 10.1091/mbc.E10-06-0512 20702581
58. Gelperin DM, White MA, Wilkinson ML, Kon Y, Kung LA, Wise KJ, et al. Biochemical and genetic analysis of the yeast proteome with a movable ORF collection. Genes Dev. 2005 Dec 1;19[23]:2816–26. Epub 2005/12/03. eng. 16322557
59. Mas P, Beachy RN. Replication of tobacco mosaic virus on endoplasmic reticulum and role of the cytoskeleton and virus movement protein in intracellular distribution of viral RNA. J Cell Biol. 1999 Nov 29;147[5]:945–58. 10579716
60. Harrison BD, Kubo S., Robinson D.J., Hutcheson A.M. The multiplication cycle of tobacco rattle virus in tobacco mesophyll protoplasts. Journal of General Virology. 1976;33:237–48.
61. Meng B, Lever AM. Wrapping up the bad news: HIV assembly and release. Retrovirology. 2013;10:5. Epub 2013/01/12. eng. doi: 10.1186/1742-4690-10-5 23305486
62. Teis D, Saksena S, Emr SD. SnapShot: the ESCRT machinery. Cell. 2009 Apr 3;137[1]:182–e1. Epub 2009/04/07. eng. doi: 10.1016/j.cell.2009.03.027 19345195
63. Jouvenet N, Zhadina M, Bieniasz PD, Simon SM. Dynamics of ESCRT protein recruitment during retroviral assembly. Nat Cell Biol. 2011 Apr;13[4]:394–401. Epub 2011/03/12. eng. doi: 10.1038/ncb2207 21394083
64. Adell MA, Vogel GF, Pakdel M, Muller M, Lindner H, Hess MW, et al. Coordinated binding of Vps4 to ESCRT-III drives membrane neck constriction during MVB vesicle formation. J Cell Biol. 2014 Apr 7.
65. Lee WM, Ahlquist P. Membrane synthesis, specific lipid requirements, and localized lipid composition changes associated with a positive-strand RNA virus RNA replication protein. J Virol. 2003 Dec;77[23]:12819–28. 14610203
66. Nikko E, Andre B. Split-ubiquitin two-hybrid assay to analyze protein-protein interactions at the endosome: application to Saccharomyces cerevisiae Bro1 interacting with ESCRT complexes, the Doa4 ubiquitin hydrolase, and the Rsp5 ubiquitin ligase. Eukaryotic cell. 2007 Aug;6[8]:1266–77. 17513562
67. Richter CM, West M, Odorizzi G. Doa4 function in ILV budding is restricted through its interaction with the Vps20 subunit of ESCRT-III. J Cell Sci. 2013 Apr 15;126(Pt 8):1881–90. doi: 10.1242/jcs.122499 23444383
68. Amerik AY, Nowak J, Swaminathan S, Hochstrasser M. The Doa4 deubiquitinating enzyme is functionally linked to the vacuolar protein-sorting and endocytic pathways. Mol Biol Cell. 2000 Oct;11[10]:3365–80. 11029042
69. Carlson LA, Briggs JA, Glass B, Riches JD, Simon MN, Johnson MC, et al. Three-dimensional analysis of budding sites and released virus suggests a revised model for HIV-1 morphogenesis. Cell host & microbe. 2008 Dec 11;4[6]:592–9. Epub 2008/12/10. eng.
70. Hanson PI, Roth R, Lin Y, Heuser JE. Plasma membrane deformation by circular arrays of ESCRT-III protein filaments. The Journal of cell biology. 2008 Jan 28;180[2]:389–402. Epub 2008/01/23. eng. doi: 10.1083/jcb.200707031 18209100
71. Votteler J, Sundquist WI. Virus budding and the ESCRT pathway. Cell host & microbe. 2013 Sep 11;14[3]:232–41. Epub 2013/09/17. eng.
72. West M, Zurek N, Hoenger A, Voeltz GK. A 3D analysis of yeast ER structure reveals how ER domains are organized by membrane curvature. The Journal of cell biology. 2011 Apr 18;193[2]:333–46. Epub 2011/04/20. eng. doi: 10.1083/jcb.201011039 21502358
73. Boucrot E, Pick A, Camdere G, Liska N, Evergren E, McMahon HT, et al. Membrane fission is promoted by insertion of amphipathic helices and is restricted by crescent BAR domains. Cell. 2012 Mar 30;149[1]:124–36. Epub 2012/04/03. eng. doi: 10.1016/j.cell.2012.01.047 22464325
74. Curtis MD, Grossniklaus U. A gateway cloning vector set for high-throughput functional analysis of genes in planta. Plant Physiol. 2003 Oct;133[2]:462–9. Epub 2003/10/14. eng. 14555774
75. Janda M, Ahlquist P. Brome mosaic virus RNA replication protein 1a dramatically increases in vivo stability but not translation of viral genomic RNA3. Proc Natl Acad Sci U S A. 1998 Mar 3;95[5]:2227–32. 9482867
76. Sullivan ML, Ahlquist P. A brome mosaic virus intergenic RNA3 replication signal functions with viral replication protein 1a to dramatically stabilize RNA in vivo. Journal of virology. 1999 Apr;73[4]:2622–32. Epub 1999/03/12. eng. 10074107
77. Lindbo JA. TRBO: a high-efficiency tobacco mosaic virus RNA-based overexpression vector. Plant Physiol. 2007 Dec;145[4]:1232–40. Epub 2007/08/28. eng. 17720752
78. Liu Y, Schiff M, Dinesh-Kumar SP. Virus-induced gene silencing in tomato. Plant J. 2002 Sep;31[6]:777–86. Epub 2002/09/11. eng. 12220268
79. Bendahmane A, Querci M, Kanyuka K, Baulcombe DC. Agrobacterium transient expression system as a tool for the isolation of disease resistance genes: application to the Rx2 locus in potato. Plant J. 2000 Jan;21[1]:73–81. Epub 2000/01/29. eng. 10652152
80. Wang X, Lee WM, Watanabe T, Schwartz M, Janda M, Ahlquist P. Brome mosaic virus 1a nucleoside triphosphatase/helicase domain plays crucial roles in recruiting RNA replication templates. J Virol. 2005 Nov;79[21]:13747–58. 16227294
81. Chen J, Ahlquist P. Brome mosaic virus polymerase-like protein 2a is directed to the endoplasmic reticulum by helicase-like viral protein 1a. J Virol. 2000 May;74[9]:4310–8. 10756046
82. den Boon JA, Chen J, Ahlquist P. Identification of sequences in Brome mosaic virus replicase protein 1a that mediate association with endoplasmic reticulum membranes. J Virol. 2001 Dec;75[24]:12370–81. 11711627
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2015 Číslo 3
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Bacterial Immune Evasion through Manipulation of Host Inhibitory Immune Signaling
- Antimicrobial-Induced DNA Damage and Genomic Instability in Microbial Pathogens
- Is Antigenic Sin Always “Original?” Re-examining the Evidence Regarding Circulation of a Human H1 Influenza Virus Immediately Prior to the 1918 Spanish Flu
- An 18 kDa Scaffold Protein Is Critical for Biofilm Formation